Evidence map›Paper›PMID 31812895›Full record

ReviewCurrent opinion in chemical biology2020

High-throughput approaches to profile RNA-protein interactions.

Misha Nechay, Ralph E Kleiner

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. RBPs: an RNA editor's choice.Frontiers in molecular biosciences · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. NovelWorld journal of clinical cases · 2022
    Article
  16. Role of m6A writers, erasers and readers in cancer.Experimental hematology & oncology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Misha NechayDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Ralph E KleinerDepartment of Chemistry, Princeton University, Princeton, NJ 08544, USA. Electronic address: rkleiner@princeton.edu.
Princeton University · US

Funding

Chemical Approaches to Illuminate the Epitranscriptome (Administrative/Equipment Supplement)R01GM132189 · NIGMS · PRINCETON UNIVERSITY · PI KLEINER, RALPH ELLIOT · 2019 to 2023
$1.6M
NIGMS NIH HHS R01 GM132189
6 · The paper itself

Abstract

RNA-protein interactions play a critical role in post-transcriptional gene regulation. Characterizing these interactions in their native context has been challenging; however, advances in RNA sequencing and mass spectrometrybased proteomics combined with innovative chemical biological tools have heralded the development of robust strategies for performing biochemistry on a cellular scale. Herein, we review recent advances in the development and application of proteomic and transcriptomic approaches to profile cellular RNA-protein interactions, focusing on sequencing-based strategies and proteomic analysis of RNA-binding proteins, as well as approaches to address the role of RNA modifications in protein-RNA binding events.

Indexed as

AnimalsBinding SitesGene Expression ProfilingHigh-Throughput Screening AssaysHumansMass SpectrometryProteinsProteomicsRNAProteinsRNACLIPProteomicsRibonomicsTranscriptomics

Identifiers

PMID31812895
PMCPMC7131871
OpenAlexW2993079926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.